Literature DB >> 17210887

Enzyme replacement for infantile Pompe disease: the first step toward a cure.

Kathryn R Wagner.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17210887     DOI： 10.1212/01.wnl.0000253226.13795.40

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Unintended effects of orphan product designation for rare neurological diseases.

Authors:  Sinéad M Murphy; Araya Puwanant; Robert C Griggs
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

2.  Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study.

Authors:  Deniz Güngör; Michelle E Kruijshaar; Iris Plug; Ralph B D'Agostino; Marloes L C Hagemans; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  Orphanet J Rare Dis       Date:  2013-03-27       Impact factor: 4.123

3.  Maltose deterioration approach: Catalytic behavior optimization and stability profile of maltase from Bacillus licheniformis KIBGE-IB4.

Authors:  Muhammad Asif Nawaz; Sidra Pervez; Muhsin Jamal; Tour Jan; Wali Khan; Abdur Rauf; Afsheen Aman; Shah Ali Ul Qader
Journal:  Biotechnol Rep (Amst)       Date:  2019-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.